PSMA PET/CT prior to biopsy?? PRIMARY trial in Eur Urol

13th September 2021

Are GU Cast overly interested in PSMA imaging and theranostics??! Yep, afraid so! So no surprise that we're featuring this very interesting prospective trial published in European Urology this week. The objective is to evaluate the role of PSMA PET/CT prior to prostate biopsy ie in the early detection space. Can this augment mpMRI? Or replace it? Or is it all just madness due to profligate access to PSMA in Australia??!
We are joined by PI Professor Louise Emmett, Nuclear Medicine Physician at St Vincent's in Sydney, to chat about the PRIMARY trial, and co-author Associate Professor Daniel Moon, Urologist at Peter MacCallum Cancer Centre who recruited close to 100 men into the trial (well done Dan!).
And for a reality check to curb our enthusiasm, we are delighted to welcome back friend of the podcast, Professor Anwar Padhani, Oncologic Radiologist and MRI guru from Mt Vernon Cancer Centre and the Institute for Cancer Research in London.
Co-hosts as ever, Professor Declan Murphy (also a co-author) and Dr Renu Eapen

Links:
GU Cast on YouTube
PRIMARY study in European Urology (paywall)
Professor Emmet Twitter
Professor Padhani Twitter
Professor Padhani Youtube
Associate Professor Moon Twitter

 

Or you can listen to the audio version here

Previous
Previous

STAMPEDE delivers yet again!

Next
Next

That Letter | Moving beyond, with Neil Fleshner, Sarah Psutka & Nathan Lawrentschuk